| abstract |
Use of a compound I, where they mean: R1 linear or branched C1-C8 alkyl or phenyl- (CH2) m-; m zero, 1 or 2; wherein the phenyl core is unsubstituted or carries one to three substituents of the groups F, Cl, CH3 or CH3O; R2 and R3 linear or branched C1-C6 alkyl, or phenyl, wherein the phenyl core is unsubstituted or carries one to three substituents of the groups F, Cl, CH3 or CH3O; or R2 and R3 can together form a ring (C5-C6), which is unsubstituted or to which condensed phenyl rings and their pharmaceutically tolerable salts are condensed for the production of a medicament for the treatment or prophylaxis of diseases caused by conditions ischemic |